Janus Henderson Group PLC Graphite Bio, Inc. Transaction History

Janus Henderson Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.14 - $5.23 $1.13 Million - $2.75 Million	-526,330 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.1 - $13.06 $2.68 Million - $6.87 Million	526,330 New	526,330 $2.68 Million
Q4 2021 Feb 14, 2022	SELL	$8.41 - $16.71 $8.06 Million - $16 Million	-958,079 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$15.81 - $28.39 $4.63 Million - $8.32 Million	-292,926 Reduced 23.42%	958,079 $15.2 Million
Q2 2021 Aug 16, 2021	BUY	$18.5 - $30.73 $23.1 Million - $38.4 Million	1,251,005 New	1,251,005 $36.7 Million

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.